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The penicillin-resistant Spain9V-3 clone of Streptococcus pneumoniae is widespread and
presents different serotype variants originating from recombination of the capsular genes. In this
work, the genetic relatedness of 29 invasive pneumococci isolated from the central region of
Argentina (Cordoba, Buenos Aires, Santa Fe and La Pampa provinces) was assessed by
multilocus sequence typing (MLST). All of the penicillin-non-susceptible isolates studied (21/29)
belonged to a serotype 14 variant of the Spain9V-3 clone. This clone was predominant,
suggesting that it was responsible for the penicillin resistance spread in this region. Interestingly,
this serotype 14 variant (named Cordoba S14V) could be differentiated from the European one by
its pbp1a gene, suggesting a different recombinational replacement of the capsular genes. The
putative recombination sites were analysed, resulting in the proximal crossover point being clearly
localized in the spr0309 gene, with the distal site restricted to the recU gene, confirming a
different recombination event. Analysis of the dexB, cpsB, aliA and pbp1a genes from these
strains showed a high similarity with the corresponding genes of the Spain14-5 clone, suggesting
that the capsular genes were provided by this international clone. Analysis of the genetic
polymorphisms of the pbp1a (nt 1473–1922) and spr0309 (nt 1–790) genes is proposed as an
epidemiological tool to help recognize the Cordoba S14V of the Spain9V-3 clone. On the other
hand, BOX-repeat-based PCR and MLST analyses of serotype 14 strains revealed a divergent
epidemiology of the Cordoba S14V, suggesting a non-recent dissemination in the paediatric
population. It is suggested that this molecular epidemiology work will be a reference for
monitoring the evolution of S14Vs of Spain9V-3, the emergence of new clones and the impact of
pneumococcal vaccination programmes in Argentina.
INTRODUCTION
Worldwide, Streptococcus pneumoniae is one of the main
human pathogens, being the causal agent of infections such
as otitis and sinusitis, as well as severe infections such as
pneumonia, bacteraemia and meningitis. In developing
countries, more than 1 million children under 5 years of
age are estimated to die annually from pneumococcal
pneumonia (Greenwood, 1999). The major epidemi-
ological concerns about pneumococcal infection are
determining the origin of emergence and the dissemination
of drug-resistant strains. Penicillin-resistant isolates were
first detected in the late 1960s, and their prevalence
increased rapidly during the 1980s. Since 1989, the
incidence of penicillin-resistant pneumococci has remained
fairly constant at about 20–30 % of all isolates (Lynch &
Zhanel, 2005). Molecular characterization of penicillin-
resistant strains from around the world has highlighted an
important diversity among isolates, but has also identified
a number of successful pneumococcal clones with a high
Abbreviations: BOX-PCR, BOX-repeat-based PCR; MLST, multilocus
sequence typing; ST, sequence type.
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level of penicillin resistance, some of which have spread
globally (Crook & Spratt, 1998). Countries such as Spain,
South Africa and Hungary reported high frequencies of
penicillin-resistant pneumococcal infections in the mid-
1970s (Fenoll et al., 1998), followed later by France, Iceland
and the USA in the mid-1980s to early 1990s (Breiman et
al., 1994; Lefevre et al., 1995). The increasing number of
penicillin-resistant clones, the diversity of the genotypes
and the serotype exchange make it difficult to assign
isolates to these clones. It is now recommended that new
genotype assignments should be made only after the strain
has undergone careful PFGE, BOX-repeat-based PCR
(BOX-PCR) or multilocus sequence typing (MLST)
analysis (McGee et al., 2001). One of the best-characterized
clones is Spain9V-3, which appears to have emerged in
Spain during the 1980s (Fenoll et al., 1991). This clone has
been prevalent in France for the last 15 years and has been
found in many other countries including Germany, the
Netherlands, Poland, Denmark, Uruguay, Argentina,
Brazil, Taiwan and South Africa (Castanheira et al., 2004;
Coffey et al., 1999; Corso et al., 1998; Hermans et al.,
1997a, b; Shi et al., 1998).
Strains that are highly related by MLST may express
different serotypes. This phenomenon is caused by a
recombinational replacement occurring in neighbouring
regions of the capsular (csp) genes. The Spain9V-3 clone has
been isolated as serotype 9A, 9V, 14 and 19 variants
(McGee et al., 2001). For the European serotype 14 variant
(S14V) of this clone (isolated in Uruguay, Denmark and
Spain), the proximal recombination site was detected in
the cspA gene, whereas the distal site was localized in the
pbp1a gene (Coffey et al., 1999).
The main purpose of this work was to assess the genetic
relatedness of invasive pneumococcal strains isolated from
children in Cordoba, Argentina, using genotypic methods
such as MLST, BOX-PCR and RFLP analysis of the
penicillin-binding protein (pbp) genes. Our results showed
that all penicillin-non-susceptible strains belonged to a new
S14V of the Spain9V-3 clone; therefore, we decided to
investigate whether this variant was similar to others
described previously by analysing the recombinational
replacement of the capsular genes and their flanking
regions. We also examined whether this S14V was
disseminated among other provinces in Argentina.
METHODS
Bacterial strains and antimicrobial susceptibility testing. All of
the pneumococcal strains were obtained from invasive infections of
paediatric patients and were collected from public children’s hospitals
of different provinces (Cordoba, Buenos Aires, La Pampa, Santa Fe
and Buenos Aires City) during the period 2003–2005. The original
Spain9V-3 clone (ATCC 700671) and the Spain14-5 clone (ATCC
700902) were utilized as references. Serotyping was performed using
the Quellung reaction with sera produced by the Statens Serum
Institut, according to the manufacturer’s instructions. For antimi-
crobial susceptibility testing, strains were grown at 37 uC in an
atmosphere of 5 % CO2 on Mueller–Hinton agar with 5 %
defibrinated sheep blood. Penicillin MICs were determined by agar
dilution following a CLSI protocol (CLSI, 2007).
RFLP analysis of pbp genes. pbp genes were amplified by PCR
using the following primers: F1a/R1a for pbp1a, F2b/R2b for pbp2b
and F2x/R2x for pbp2x (Table 1). The reaction mixtures contained
2 mM MgCl2, 0.5 mM each dNTP and 2 U Taq DNA polymerase
(Invitrogen). PCR was performed using a Bio-Rad Gene Cycler for 30
cycles of 95 uC for 1 min, 53 uC for 30 s and 72 uC for 45 s. Purified
PCR product (1 mg) was digested with MseI/DdeI (3 U each enzyme)
or 2 U HinfI for 2 h at 37 uC and analysed by 7 % non-denaturing
PAGE.
PCR conditions. For amplification of the pbp1a DNA fragments, the
primer pairs F1a/R1a2, F1aS/R1aS, F1aM/R1aM and F1aF/R1a were
utilized. An internal fragment of the cpsB gene was amplified using
the primers cpsB-down (Coffey et al., 1998) and cpsS3 (Kong &
Gilbert, 2003). These PCR products were all amplified using the
following PCR parameters: initial denaturation at 94 uC for 4 min, 35
cycles of denaturation at 94 uC for 45 s, annealing at 55 uC for 30 s
and elongation at 72 uC for 1 min, and a final extension at 72 uC for
10 min. A 639 bp internal fragment from the dexB gene and an
842 bp internal fragment from the aliA gene were amplified using the
primer pairs Fdex/Rdex and Fali/Rali, respectively. The PCR
parameters were initial denaturation at 94 uC for 4 min, followed
by 35 cycles of 94 uC for 1 min, 52 uC for 45 s and 72 uC for 1 min.
The spr0309 and recU genes were amplified using the primer pairs
Fspr/Rspr and FrecU/RrecU, respectively. All primer sequences are
shown in Table 1. Chromosomal DNA was isolated using a Wizard
Genomic DNA purification kit (Promega) following the manufac-
turer’s instructions. The PCR products were amplified from
chromosomal DNA and sequenced in both directions using the
primers used for amplification. The cpsB sequences from the
Baltimore strains were kindly provided by Dr Lee Harrison
(McEllistrem et al., 2004).
MLST. MLST was performed as described previously (http://
www.mlst.net). The internal fragments from the aroE, gdh, gki, recP,
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spi, xpt and ddl genes were amplified by a PCR utilizing primers
described previously (Enright & Spratt, 1998). DNA sequencing was
performed by Macrogen and DNA sequences were edited using
BioEdit software (Hall, 1999). Alleles and sequence types (STs) were
assigned using the database available at http://www.mlst.net.
BOX-PCR typing. The BOX elements were amplified from genomic
DNA using the primer BOXA1R (Koeuth et al., 1995). The reaction
conditions were 30 cycles of denaturation at 95 uC for 1 min,
annealing at 52 uC for 2 min and elongation at 72 uC for 2 min. PCR
was performed using a PTC-100 MJR thermal cycler. PCR products
were analysed by electrophoresis on a 2 % TAE/agarose gel.
RESULTS
Determination of the genetic relatedness of
invasive pneumococcal strains
Initially, 66 invasive pneumococcal strains were isolated
from children under 5 years of age attending public
children’s hospitals in Cordoba, Argentina, during the
period 2003–2005, and 20 of these were non-susceptible to
penicillin (Table 2). To analyse the genetic relationship of
this pneumococcal population by MLST, we selected nine
penicillin-non-susceptible isolates with a high penicillin
MIC and eight penicillin-susceptible isolates, based on the
serotype prevalence in our region. The results showed that
all penicillin-non-susceptible strains belonged to the S14V
of the Spain9V-3 clone. Seven strains presented an identical
allelic profile to ST156 and two strains showed a single-
locus variant, ST370 (Table 3). To test the clonal evolution
of the Cordoba S14V strains, we used molecular markers
that diverge more frequently than housekeeping genes,
such as BOX-PCR and RFLP of pbp genes. Our Spain9V-3
strains showed five BOX profiles (data not shown),
indicating an epidemiological divergence of this clonal
complex and a non-recent dissemination in the paediatric
population. All nine penicillin-non-susceptible strains
isolated from Cordoba showed identical pbp RFLP patterns
(pbp1a/AluI, HinfI or MseI/DdeI, pbp2b/HinfI and pbp2x/
HinfI; data not shown), indicating a lower discriminatory
power than BOX-PCR.
The penicillin-susceptible strains showed genetic diversity
by MLST and were classified into minor international
clones (Table 4). Two of the eight strains presented
different serotypes to those described originally, namely a
serotype 7F variant of the England14-9 clone and a S14V of
the Sweden15A-25 clone. We also found two new STs, 2240
and 2241, which we registered in the MLST database.
Analysis of the capsular gene region to detect
recombinational replacements
It has been reported that a S14V of the Spain9V-3 clone
isolated in Baltimore (MD, USA) could be differentiated
from the original Spain9V-3 clone (serotype 9V) by cpsB
gene polymorphisms (in the 72–548 region) and from the
Uruguayan/European variant by the pbp1a gene (in the
1498–1710 region) (McEllistrem et al., 2004). To determine
whether our S14V was derived from the other S14Vs that
have been described, the cpsB (72–548 region) and pbp1a
(1–2160 region) genes were amplified and sequenced. All
nine Cordoba S14V strains showed identical cpsB
sequences to the Baltimore S14V and presented one
polymorphism at position 446 compared with the
European S14V. However, there was a 17 % divergence
(82 out of 476 bp) from the original Spain9V-3 clone
(Fig. 1). For the pbp1a gene, from position 1473 to 1922,
Table 2. Phenotypic and molecular characterization of non-
susceptible strains isolated from Cordoba
Cba, Cordoba; CSF, cerebrospinal fluid; NT, not typable.
Strain Isolation site Serotype BOX profile Penicillin
MIC
(mg ml”1)
Cba-6 Blood 14 A .4
Cba-10 Blood 14 A 1
Cba-19 Blood 14 D 2
Cba-22 Pleural fluid 14 A 2
Cba-28 CSF 14 B 4
Cba-33 Blood 14 C 2
Cba-46 Blood 14 E 2
Cba-55 Blood 14 D 2
Cba-62 Blood 14 B 2
Cba-43 Blood NT G 1
Cba-44 Blood 19F B 0.5
Cba-45 Blood 14 B 1
Cba-50 Blood NT B 0.12
Cba-52 Blood 14 B 2
Cba-54 Pleural fluid 14 B 1
Cba-56 Blood 23F I 0.25
Cba-80 CSF 14 A 1
Cba-85 Blood 14 A 0.25
Cba-98 Blood 6B D 0.75
Cba-112 Blood 14 A 0.25
Table 3. Molecular characterization of the penicillin-non-
susceptible Cordoba S14Vs of the Spain9V-3 clone
Strain* MLST allele number ST
aroE gdh gki recP spi xpt ddl
Cba-6 7 11 10 1 6 8 1 156
Cba-10 7 11 10 1 6 8 1 156
Cba-19 7 11 10 1 6 8 1 156
Cba-22 7 11 10 1 6 8 1 156
Cba-28 7 11 10 1 6 3 1 370
Cba-33 7 11 10 1 6 8 1 156
Cba-46 7 11 10 1 6 8 1 156
Cba-55 7 11 10 1 6 8 1 156
Cba-62 7 11 10 1 6 3 1 370
*Cba, Cordoba.
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the Cordoba S14V was identical to the Baltimore S14V
(McEllistrem et al., 2004) and to the Spain14-5 clone, but
had 60 bp differences compared with the original Spain9V-
3 clone and the European S14V (Coffey et al., 1999)
(Fig. 2). From position 1473 to 1872, our strains were also
different to the Polish S14V (Coffey et al., 1999) with 48
polymorphisms, but were identical to the Polish and
Baltimore S14Vs from position 1873 to 1922. A single
polymorphism at position 2045 was present only in the
Cordoba variant and the Spain14-5 clone, although the
DNA sequence of this pbp1a region was not available for
the Baltimore S14V (Fig. 2). All of these results suggested
that the Baltimore S14V and our S14Vs had similar clonal
origins, and that both had a different clonal origin to the
European S14V, also suggesting a different capsular
replacement. It has been proposed that serotype variants
of penicillin-non-susceptible clones have arisen by recom-
binational exchanges at the capsular biosynthetic locus, cps.
Molecular evidence in support of this hypothesis was
reported for the European S14V, which arose by large
Table 4. Phenotypic and molecular characterization of penicillin-susceptible strains isolated from Cordoba
Strain Isolation site Serotype Antibiotic
susceptibility*
MLST allele number ST Clonal complex
aroE gdh gki recP spi xpt ddl
Cba-2 Blood NT S 7 2 1 10 27 4 14 148
Cba-5 Blood 18C S 7 2 1 1 10 1 21 113 Clone 36
Cba-8 Pleural fluid NT S 8 9 2 1 6 1 17 191 Clone 39
Cba-21 Blood 9A S 15 17 4 1 6 1 17 2240D
Cba-23 Blood 6B S 7 47 29 1 6 1 80 2241D
Cba-24 Blood 7F S 1 5 4 5 5 1 8 9 England14-9
Cba-25 Pleural fluid 6B S 7 47 29 1 6 1 80 2241D
Cba-32 Blood 14 S 2 5 36 12 17 21 5 782 Sweden15A-25
NT, Not typable.
*Susceptibility to erythromycin, rifampicin, trimethoprim/sulfamethoxazole, vancomycin and chloramphenicol.
DNew STs registered in the MLST database.
Fig. 1. Comparison of polymorphic sites within the spr0309–cpsB region. The DNA sequences shown correspond to the
spr0309–cpsB region from different serotype variants of the Spain9V-3 clone: Sp9V-3, original Spain9V-3 clone (ATCC
700671); URU, S14V strains of the Spain9V-3 clone isolated in Uruguay (Coffey et al., 1999); BALT, S14V strains of the
Spain9V-3 clone isolated in Baltimore (strain I) (McEllistrem et al., 2004); Cba, S14V strains of the Spain9V-3 clone isolated in
Cordoba. The Sp9V-3 sequence is shown as a reference and identical sites in other strains are represented by dots, with only
polymorphisms being indicated. The nucleotide numbers of the polymorphic sites are indicated vertically and are positioned
according to the transcription sense indicated by arrows. The symbol ‘/’ represents unsequenced DNA regions. The solid arrow
indicates the proximal crossover point of the recombinational replacement. This site is located at position 198 of the spr0309
gene from the Cordoba S14V of the Spain9V-3 clone. Position 446 of the cpsB gene is underlined. The DNA sequences from
the Buenos Aires, Santa Fe and La Pampa strains were identical to that of the Cordoba strains; therefore we used Cba-6 as a
representative strain.
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recombinational replacements in the cpsA–pbp1a region
(Coffey et al., 1999). The cps locus contains a series of
alphabetically named capsular genes, which are flanked by
the conserved genes dexB and aliA (Fig. 3). In the European
S14V, the crossover point of the proximal end was localized
to the cpsA gene (Coffey et al., 1999). To identify this point
in our isolates, the DNA region upstream from the cpsB gene
was analysed. We found that partial dexB sequences of the
Cordoba S14V strains were different from that of the
original Spain9V-3, indicating that the crossover occurred
upstream from dexB (Fig. 3). Consequently, the spr0309
gene (as named in the R6 strain, or SP0341 in the TIGR4
strain) of three strains (Cba-6, -10 and -28) was amplified
and sequenced. The recognition of a divergent block at
position 198 of spr0309 revealed the proximal crossover
point of the recombinational exchange that introduced the
serotype 14 cps locus into our S14Vs (Fig. 1). The distal
crossover point of the European S14V was localized in pbp1a
(Coffey et al., 1999). We could not identify the distal
crossover point along the pbp1a sequences from Cordoba
isolates. Based on the identical sequence homology found in
the 59 region of the pbp1a gene and for the complete recU
gene among our strains and the Spain14-5 and Spain9V-3
clones, we suspected that the distal crossover point could be
along this region (Fig. 2). To study the continuity of the
extensive recombinational replacement in the spr0309–recU
region, aliA, a gene located approximately in the centre of
the replaced DNA region (Fig. 3), was also analysed. Its DNA
sequence showed differences from that of the original
Spain9V-3, but complete sequence similarity with the same
gene described in the Spain14-5 clone (data not shown). This
result was in agreement with the other gene analyses and
suggested no interruption of the DNA replacement, which
apparently was provided by the Spain14-5 clone.
Fig. 2. Polymorphic sites within the pbp1a gene from different strains. See Fig. 1 legend for details of the different serotype
variants; Sp14-5 indicates the Spain14-5 clone (ATCC 700902). From position 1711 to 1874 and from position 2000 to the
end of the sequence, our strains were identical to the Spain9V-3 clone, except for a single polymorphism at position 2045,
which was found only in the Spain14-5 clone. The DNA sequences from the Buenos Aires, Santa Fe and La Pampa strains were
identical to that of the Cordoba strains; therefore, we used Cba-6 as a representative strain. The Uruguayan (URU) and Polish
(POL) pbp1a sequences were obtained from Coffey et al. (1999).
Fig. 3. Graphic representation of the possible recombinational replacements from which the Cordoba S14V of the Spain9V-3
clone may have originated. The srp0309–recU region is shown as an open box for the original Spain9V-3 clone, as a filled box
for the Spain14-5 clone, and is shaded for an unknown serotype 14 strain. DNA regions that were introduced by recombination
from a serotype 14 donor into a serotype 9V receptor are shown as filled or shaded zones. Horizontal arrows below the
Cordoba S14V represent the regions that were amplified and sequenced. A solid cross indicates the proximal crossover point
identified in the srp0309 gene. The distal site of the recombinational replacement was not clearly detected. The hatched area
represents the zone where the unidentified crossover event is expected to have occurred.
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Detection of the Cordoba S14V in other provinces
As this new S14V was predominant in Cordoba, we
decided to investigate the putative dissemination of this
subclone in different geographical regions near this
province. Consequently, we requested invasive serotype
14 strains from children’s hospitals located in other
regions, such as Buenos Aires City and the provinces of
Buenos Aires, Santa Fe and La Pampa, covering an
approximate area of 800 km2. We obtained 12 penicillin-
non-susceptible strains recovered from blood cultures that
corresponded to serotype 14 and these were analysed by
MLST (Table 5). Ten isolates were ST156; however, we
identified two new sequence types, ST3119 and ST3120,
which presented a single locus variant of the allelic profile
of the Spain9V-3 clone. To identify whether these strains
belonged to the Cordoba S14V, the genetic polymorphisms
of the pbp1a (nt 1473–1922) and spr0309 (nt 1–790) genes
were analysed and their sequences were found to be
identical to those found in the S14V isolated in Cordoba
(Figs 1 and 2). These results suggested that the Cordoba
S14V is disseminated in the central provinces correspond-
ing to the most densely populated regions of Argentina
(Fig. 4).
DISCUSSION
In this work, we determined the genetic background of
invasive pneumococcal strains circulating in Cordoba,
showing that a new S14V of the Spain9V-3 clone is
predominant among penicillin-non-susceptible strains and
is disseminated in the central region of Argentina.
Previously, a PFGE-based molecular epidemiological study
indicated that a S14V of the Spain9V-3 clone was
predominant among penicillin-non-susceptible isolates in
Argentina (Rossi et al., 1998). Another epidemiological
study conducted by the Pan American Health Organization
analysed invasive pneumococcal strains isolated from
children under 5 years of age in six Latin-American
countries from 1993 to 1996 (Tomasz et al., 1998). This
PFGE study revealed that the Spain9V-3 and Spain23F-1
clones were highly represented in these countries and that a
S14V of the Spain9V-3 clone showed greater than 80 %
prevalence in Argentina and Uruguay, with penicillin MICs
of greater than 1 mg ml21. The identical PFGE profile
identified in Argentina and Uruguay suggested that the
clonal origin was common, and that the importation of this
clone in both countries was coincident in time. The
majority of these isolations were detected in large cities,
sustaining the hypothesis that the spread of these clones
has been facilitated by international travel (Tomasz et al.,
1998). However, a detailed molecular characterization of
the Cordoba S14V revealed that its epidemiological history
is different to that of the Uruguayan strains. Coffey et al.
(1999) described several Uruguayan strains with identical
ST profiles and pbp1a sequences to those of the European
S14V. However, in contrast, we found clear differences
between the Cordoba and European S14Vs, suggesting that
a different recombinational event has occurred in Cordoba
to that which occurred in Uruguayan strains. We found
that the proximal crossover point in our strains was located
precisely in the spr0309 gene (Fig. 1), confirming a new
recombinational event. When dexB, cpsB, aliA and pbp1a
sequences were analysed, they were found to be identical to
the homologous genes described in the Spain14-5 clone,
indicating that the origin of serotype 14 cps genes was this
international clone and not other serotype 14 strains, as
occurring in the European S14V. In contrast to the
proximal site, the distal crossover point was not clearly
identified. The 1473–1922 region of pbp1a was identical
between our strains and the Spain14-5 clone, but we found
60 bp differences compared with the European S14V. Also,
the pbp1a sequences (2000–2160 region) were identical for
the original Spain9V-3 clone, the Spain14-5 clone and our
Table 5. Phenotypic and molecular characterization of the Cordoba S14Vs of the Spain9V-3 clone isolated from other provinces
Strain* Isolation site Serotype BOX
profile
MLST allele number ST Penicillin MIC
(mg ml”1)
aroE gdh gki recP spi xpt ddl
BsAs-1 Blood 14 B 7 11 10 1 6 8 1 156 4
BsAs-2 Blood 14 B 7 11 10 1 6 8 1 156 2
BsAs-3 Blood 14 B 5 11 10 1 6 8 1 3119 2
BsAs-4 Blood 14 B 7 11 10 1 6 8 1 156 2
BsAs-5 Blood 14 B 7 11 10 1 6 8 1 156 2
BsAs-6 Blood 14 B 7 11 10 1 6 8 1 156 2
BsAs-7 Blood 14 B 7 11 10 1 6 8 1 156 2
BsAs-8 Blood 14 B 7 11 10 1 6 8 1 156 2
BsAs-9 Blood 14 B 7 11 10 1 6 8 1 156 2
LaPam Blood 14 B 7 11 10 1 6 8 1 156 2
Sta Fe-1 Blood 14 B 7 2 10 1 6 8 1 3120 2
Sta Fe-2 Blood 14 B 7 11 10 1 6 8 1 156 2
*BsAs, Buenos Aires; LaPam, La Pampa; Sta Fe, Santa Fe.
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clones, except that the Spain9V-3 clone did not have a
polymorphism at position 2045. Up to this position, we
consider that the replaced DNA region in our strains
belongs to the Spain14-5 clone, but after this site, we could
not detect a divergent block in the DNA sequences from
these clones. For this reason, we assume that the distal
crossover occurred in the recU region.
Here, we have described a new capsular replacement in the
predominant penicillin-non-susceptible Spain9V-3 clone,
with this phenomenon also being observed in penicillin-
susceptible isolates. We found that the Cba-32 strain was
serotype 14 and ST782, belonging to the Sweden15A-25
clone (Table 4). In addition, the Cba-24 strain was serotype
7F and ST9, corresponding to the England14-9 clone. In
this case, this capsular replacement has relevance in the
application of vaccination programmes, as serotype 7F is
currently not included in the vaccine formulation, and this
is therefore a risk to be taken into account when
considering the pneumococci circulating in our paediatric
population.
Due to the geographical proximity with Uruguay, and also
the active tourist exchange with our country, we expected
to find the same S14V as that observed in Uruguay.
However, the Uruguayan S14V presented the same genetic
profile as the European S14V (Coffey et al., 1999). From an
MLST analysis of our 21 strains belonging to the Spain9V-3
clone, 17 strains were ST156, two were ST370 and two were
new STs, ST3119 and ST3120, which were single variants of
ST156. By coincidence, a search in the MLST database
(http://spneumoniae.mlst.net) showed three STs associated
with S14V strains isolated in Uruguay: the original ST156
and two single variants in the xpt allele, which were
represented by ST164 and ST168. These data revealed that
the ST divergence was different in Argentina. Analysis of
the BOX regions, an evolutionary marker that diverges
more frequently than housekeeping genes, suggested that
the Spain9V-3 clone was not disseminated recently in
Argentina.
All of our Spain9V-3 strains presented reduced penicillin
(Tables 2 and 4) and cefotaxime (data not shown)
susceptibility. Castanheira et al. (2003) analysed a cefotax-
ime-resistant population isolated from six Latin-American
countries. A major clone, which presented serotype 14 and
the same ribotype as Spain9V-3, was present in Argentina,
Brazil, Chile and Uruguay. However, the Argentinean and
Uruguayan strains showed small differences in the PFGE
analysis. Therefore, we may assume that our S14V is the
source of the cefotaxime resistance in Cordoba and also in
other parts of Argentina, but not in Uruguay.
So far, characterization of the Cordoba S14V has shown the
same genetic profile as that of the Baltimore S14V. There
are no data about the putative crossover points of the
serotype 14 cps genes of the Baltimore strains, but when we
analysed the published cpsB and pbp1a sequences
(McEllistrem et al., 2004), we also found homology with
the Spain14-5 clone, suggesting that the cps cassette had the
same origin. Here, we have performed a relevant
characterization of this new S14V of the Spain9V-3 clone
that should be considered for further epidemiological
studies to determine whether these S14V strains are
disseminated in other countries and also where this clone
originated. For this, we propose that the pbp1a (nt 1473–
1922 region) and spr0309 (nt 1–790 region) genes should
be utilized to help recognize the Cordoba S14V. We suggest
that the results of this study will provide a reference for
monitoring the evolution of the variants of Spain9V-3, the
emergence of new clones and the impact of pneumococcal
vaccination programmes in Argentina.
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